Authors
Latest:
Concerns Persist about the 340B ProgramCreated in 1992 as part of the Veterans Health Care Act, the 340B drug pricing program requires drug companies to provide discounts sometimes as much as 50% to covered entities, hospitals, and clinics that treat low-income and uninsured patients.
Latest:
High Carbohydrate Diet May Increase Mortality Risk in Certain CancersThe findings suggest that a patient’s diet may impact their ability to combat head and neck cancer.
Latest:
Pediatric Asthma Treatment Prescribing Needs ImprovementPrescribed dosage of aminophylline in children with acute severe asthma may not improve the condition.
Latest:
Comparative Effectiveness of TNF Blockers in Rheumatoid Arthritis PatientsAmong rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.
Latest:
Outpatient Cancer Center Cost Evaluation of Extended Beyond-Use Dating with a Closed-System Transfer DeviceThere is a constant balancing act for health care systems to provide the newest and most up-to-date care for patients while being financially responsible.
Latest:
Lung Cancer: Copayments and Behavior Following Erlotinib Formulary Tier ChangeMoving erlotinib from formulary tier 3 to tier 2 resulted in lower copayments and higher treatment persistence among lung cancer patients.
Latest:
Zooming Through the Pandemic: NSU Virtual AMCP Student ChapterThere are many benefits to adopting and integrating new technological methods for hosting pharmacy organization events.
Latest:
Outpatient Adherence to Risperidone Long-Acting Injection Following Discharge From a State Psychiatric HospitalAdherence to risperidone long-acting injection (RLAI) therapy in the outpatient setting was poor. Degree of discharge planning from inpatient hospitalization was not associated with RLAI adherence.
Latest:
Novel Therapies in Atopic DermatitisAtopic dermatitis (AD) is among the most common chronic inflammatory skin disorders in the Western world, with studies suggesting that 10.7% of the US population is affected.
Latest:
Probiotics for Prevention: Can You 'C' a DIFFerence?Probiotics may offer a potential treatment for clostridium difficile infection.
Latest:
Evidence-Based Adherence Classes for Combination Antihypertensive, Lipid-Lowering, and Antidiabetic TherapyAdherence classes were determined for patients taking multiple medications (ie, lipid-lowering, antihypertensive, antidiabetic) and were found to be related to serum profiles and risk of adverse events.
Latest:
Medication Management: Measuring What MattersAs new care delivery models evolve to focus on value, accountability, and team-based care, new measure development opportunities exist to address care gaps and to support team-based care delivery systems and care transitions.
Latest:
Regulatory Deharmonization: How Brexit May Effect the Medical Products Industry, Public HealthHow changes related to Brexit may influence regulatory, research, and economic perspectives, as well as human health.
Latest:
OTC, Prescription Drug Abuse Increasing Among AdolescentsNeighborhood pharmacists can provide support and information.
Latest:
Do Units and Costs of Comparable Insulins Differ by Manufacturer?Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.
Latest:
Managing Schizophrenia: The Role of Pharmacies in Providing Continuing CareAs providers of long-acting treatment injections, pharmacists can positively impact medication adherence.
Latest:
Implications of the BRIDGE Trial: Should We Forgo Perioperative Anticoagulation?Atrial fibrillation is characterized by abnormal impulse formations that cause the heart to beat irregularly.
Latest:
The Unintended Side Effects of the Specialty Pharmacy Service ModelThe evolution of specialty pharmacy has raised the stakes for the services that patients expect during treatment.
Latest:
Health-System Perspectives on Oncology Market Access in 2018There is an ongoing shift toward many cancer types being treated as maintenance diseases, which places a significant financial burden not only on patients, but also payers and providers within the health care industry.
Latest:
Sliding-Scale Insulin: Time to Say Goodbye?A recent retrospective analysis showed that nearly 75% of long-term care patients with diabetes received SSI.
Latest:
Insulin Pump Therapy and Continuous Glucose MonitoringInsulin pump therapy and continuous glucose monitoring systems can be invaluable tools for patients with type 1 and type 2 diabetes.
Latest:
Cancer Patients Require Coordinated CareTreatment advances have made many cancers a chronic disease rather than a terminal disease. Here is how one dedicated team works to coordinate care and work with patients.
